(Q41861130)

13 October 2017

title

Relative lipophilicities and structural-pharmacological considerations of various angiotensin-converting enzyme (ACE) inhibitors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1475237

30 September 2022

1 reference

ChEBI release 2020-05-28

S. A. Ranadive

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1475237

30 September 2022

A. X. Chen

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1475237

30 September 2022

A. T. Serajuddin

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1475237

30 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1475237

30 September 2022

publication date

1 November 1992

1 reference

13 October 2017

published in

Pharmaceutical Research

1 reference

13 October 2017

volume

9

1 reference

13 October 2017

issue

11

1 reference

13 October 2017

page(s)

1480-1486

1 reference

Differential renal handling of angiotensin-converting enzyme inhibitors enalaprilat and lisinopril in rats

13 October 2017

cites work

1 reference

12 December 2020

Differentiation of angiotensin-converting enzyme (ACE) inhibitors by their selective inhibition of ACE in physiologically important target organs

1 reference

12 December 2020

Lisinopril. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure

1 reference

12 December 2020

Disposition of zofenopril calcium in healthy subjects

1 reference

12 December 2020

Clinical pharmacokinetics of the angiotensin converting enzyme inhibitors. A review

1 reference

12 December 2020

Rational design and biochemical utility of specific inhibitors of angiotensin-converting enzyme

1 reference

12 December 2020

Preferential biliary elimination of FPL 63547, a novel inhibitor of angiotensin-converting enzyme, in the rat.

1 reference

12 December 2020

Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive Agents

1 reference

12 December 2020

Quantitative structure-pharmacokinetic relationships derived on antibacterial sulfonamides in rats and its comparison to quantitative structure-activity relationships.

1 reference

12 December 2020

Hydrophobicity and central nervous system agents: on the principle of minimal hydrophobicity in drug design

1 reference

12 December 2020

Disposition of fosinopril sodium in healthy subjects

1 reference

12 December 2020

Passive and carrier-mediated intestinal absorption components of two angiotensin converting enzyme (ACE) inhibitor prodrugs in rats: enalapril and fosinopril

1 reference

12 December 2020

Biliary excretion and conjugation of diacid angiotensin-converting enzyme inhibitors

1 reference

12 December 2020

Pharmacokinetics of fosinopril in patients with various degrees of renal function

1 reference

12 December 2020

Inhibition of converting enzyme in the cerebrospinal fluid of rats after oral treatment with converting enzyme inhibitors

1 reference

12 December 2020

Pharmacokinetics and biotransformation of 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S, 5S)-2-azabicyclo [3.3.0]octane-3-carboxylic acid (Hoe 498) in rat, dog and man

1 reference

12 December 2020

Brain uptake of radiolabeled amino acids, amines, and hexoses after arterial injection

1 reference

12 December 2020

Structural relationships of angiotensin converting-enzyme inhibitors to pharmacologic activity

1 reference

12 December 2020

Enalapril maleate (MK-421), a potent, nonsulfhydryl angiotensin-converting enzyme inhibitor: absorption, disposition, and metabolism in man

1 reference

12 December 2020

Recent developments in the design of angiotensin-converting enzyme inhibitors

1 reference

12 December 2020

Passive and carrier-mediated intestinal absorption components of captopril

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1015823315983

1 reference

13 October 2017

1 reference